Noel P. Bouck
Affiliations: | Northwestern University, Evanston, IL |
Area:
Cell BiologyGoogle:
"Noel Bouck"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Huang H, Campbell SC, Nelius T, et al. (2004) Alpha1-antitrypsin inhibits angiogenesis and tumor growth. International Journal of Cancer. 112: 1042-8 |
| Boehm BO, Lang G, Feldmann B, et al. (2004) Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. a pilot study. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme. 35: 382-6 |
| Doll JA, Stellmach VM, Bouck NP, et al. (2003) Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nature Medicine. 9: 774-80 |
| Boehm BO, Lang G, Volpert O, et al. (2003) Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy. Diabetologia. 46: 394-400 |
| Holekamp NM, Bouck N, Volpert O. (2002) Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. American Journal of Ophthalmology. 134: 220-7 |
| Bouck N. (2002) PEDF: anti-angiogenic guardian of ocular function Trends in Molecular Medicine. 8: 330-334 |
| Volpert OV, Zaichuk T, Zhou W, et al. (2002) Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nature Medicine. 8: 349-57 |
| Reiher FK, Volpert OV, Jimenez B, et al. (2002) Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics. International Journal of Cancer. 98: 682-9 |
| Doll JA, Reiher FK, Crawford SE, et al. (2001) Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate. The Prostate. 49: 293-305 |
| Lawler J, Miao WM, Duquette M, et al. (2001) Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. The American Journal of Pathology. 159: 1949-56 |